i-test COVID-19 Antigen Test
Commercial- Indications
- COVID-19
Company intelligence / Profile preview
Sentromer has developed a broad portfolio of molecular diagnostic products including real-time PCR kits for pathogen identification in clinical and food samples; rapid antigen/antibody test kits for infectious diseases such as COVID‑19 and Influenza; synthetic oligonucleotide production services; bioinformatics support; and custom R&D projects in molecular biology fields. The company is ISO 9001:2018 and ISO 13485:2015 certified.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sentromer DNA Technologies.